Cover Image

Author reply to "Heterologous mRNA-based COVID-19 booster strategies: Comment"

Saved in:

Bibliographic Details
Main Authors:	Rituparna Das (Author), Randall N. Hyer (Author), Paul Burton (Author), Jacqueline M. Miller (Author), Barbara J. Kuter (Author)
Format:	Book
Published:	Taylor & Francis Group, 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape
by: Rituparna Das, et al.
Published: (2023)

Heterologous mRNA-based COVID-19 booster strategies: Comment
by: Sora Yasri, et al.
Published: (2023)

A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children
by: Frances Priddy, et al.
Published: (2024)

Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine
by: Qian Chen, et al.
Published: (2023)

Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
by: Fanglei Zuo, et al.
Published: (2023)

Side Effects after mRNA COVID-19 Vaccine as a Booster in Health Workers
by: Temmasonge Radi Pakki, et al.
Published: (2022)

Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS study
by: Wataru Mimura, et al.
Published: (2024)

Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines
by: Moe H. Kyaw, et al.
Published: (2023)

Authors' Reply to Comments from Dr. Guan
by: Ken-ichiro Inoue, et al.
Published: (2009)

mRNA as a Therapeutics: Understanding mRNA Vaccines
by: Ferdi Oğuz, et al.
Published: (2022)

Multi-epitope mRNA vaccine candidate to combat HMPV virus: Comment
by: Hinpetch Daungsupawong, et al.
Published: (2024)

A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants
by: Shugang Qin, et al.
Published: (2023)

Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
by: Jingjing Lv, et al.
Published: (2022)

Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Author's reply to correspondence
by: Giancarlo Ripabelli, et al.
Published: (2023)

The Author Reply: A Comment on "Quaternary Prevention in Public Health"
by: Jong-Myon Bae
Published: (2016)

Authors' Reply
by: Piyush Kumar, et al.
Published: (2016)

Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant
by: Gabiria Pastore, et al.
Published: (2024)

No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial
by: Abdi Naficy, et al.
Published: (2024)

Significant increase in anti-SARS-CoV-2 antibodies after administration of heterologous mRNA-based vaccine booster in individuals receiving two doses of inactivated COVID-19 vaccine: A single-center study in healthcare workers in Jakarta, Indonesia
by: Wuryantari Setiadi, et al.
Published: (2023)

Response to the comments on "Acute psychosis induced by mRNA-based COVID-19 vaccine in adolescents"
by: Yeh-Li Lien, et al.
Published: (2023)

Authors' reply to critical comment on "Vitamin D level in alopecia areata"
by: Yasmeen Jabeen Bhat, et al.
Published: (2018)

PEGylation of mRNA by Hybridization of Complementary PEG-RNA Oligonucleotides Stabilizes mRNA without Using Cationic Materials
by: Naoto Yoshinaga, et al.
Published: (2021)

Spliceosome-Mediated Pre-mRNA trans-Splicing Can Repair CEP290 mRNA
by: Scott J. Dooley, et al.
Published: (2018)

Ziwuliuzhu Acupuncture Modulates Clock mRNA, Bmal1 mRNA and Melatonin in Insomnia Rats
by: Ao Huang, et al.
Published: (2023)

Translational kinetic‐pharmacodynamics of mRNA‐6231, an investigational mRNA therapeutic encoding mutein interleukin‐2
by: Ivana Liric Rajlic, et al.
Published: (2024)

Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression
by: Aditya R. Darade, et al.
Published: (2022)

Efficient mRNA Delivery with mRNA Lipoplexes Prepared Using a Modified Ethanol Injection Method
by: Min Tang, et al.
Published: (2023)

Lipid carriers for mRNA delivery
by: Wanting Zhang, et al.
Published: (2023)

Nanobiotechnology-Enabled mRNA Stabilization
by: He Xian, et al.
Published: (2023)

Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024)

mRNA delivery in cancer immunotherapy
by: Yichen Zhong, et al.
Published: (2023)

Polyester materials for mRNA delivery
by: Wang Chen, et al.
Published: (2022)

mRNA, a Revolution in Biomedicine
by: Bruno Baptista, et al.
Published: (2021)

Heterologous COVID-19 vaccination in pregnant women: Comment
by: Pathum Sookaromdee, et al.
Published: (2023)

mRNA Lipoplexes with Cationic and Ionizable α-Amino-lipophosphonates: Membrane Fusion, Transfection, mRNA Translation and Conformation
by: Sohail Akhter, et al.
Published: (2022)

Author's reply
by: Sukhyanti Kerai, et al.
Published: (2011)

Author's Reply
by: Farid E Stephan, et al.
Published: (2016)

Author's reply
by: Nidhi Jindal
Published: (2015)

Authors' reply
by: Ali Mohammad Malekasgar, et al.
Published: (2011)

Author's Reply
by: Corresponding Author
Published: (2022)